FUSION · 257MS201
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A phase 2 study evaluating the efficacy and safety of BIIB091 monotherapy and combination therapy with diroximel fumarate in participants with relapsing multiple sclerosis. EudraCT: 2022-502552-31-00.
Sponsor: BIOGEN
Phase: II
Area: Neuroimmunology